Biblio
Distinct ontogenetic lineages dictate cDC2 heterogeneity. Nat Immunol. 2024.
Immune-monitoring of myelodysplastic neoplasms: Recommendations from the i4MDS consortium. Hemasphere. 2024;8(5):e64.
.
CKS1 inhibition depletes leukemic stem cells and protects healthy hematopoietic stem cells in acute myeloid leukemia. Sci Transl Med. 2022;14(650):eabn3248.
Integrated OMICs unveil the bone-marrow microenvironment in human leukemia. Cell Rep. 2021;35(6):109119.
Engineering human hematopoietic environments through ossicle and bioreactor technologies exploitation. Exp Hematol. 2020.
. How to say NO to vascular disruption and stem cell mobilization. Expert Opin Ther Targets. 2018.
. APOBEC3A Is Implicated in a Novel Class of G-to-A mRNA Editing in WT1 Transcripts. PLoS One. 2015;10(3):e0120089.
. CD123 AML targeting by chimeric antigen receptors: A novel magic bullet for AML therapeutics?. Oncoimmunology. 2014;3:e28835.
. Mesenchymal stem cell biodistribution, migration, and homing in vivo. Stem Cells Int. 2014;2014:292109.
. .